Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
Clinical trial NCT04735978 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04735978
- Sponsor
- Replimune, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2026-11-30
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.